Year |
Citation |
Score |
2023 |
Dalrymple KL, Wahrer KS, Walsh E, Rosenstein L, Zimmerman M. A Pilot Randomized Controlled Trial of the Feasibility and Acceptability of Acceptance and Commitment Therapy for Comorbid Social Anxiety Disorder in a Routine Practice Setting. Journal of Cognitive Psychotherapy. PMID 37369538 DOI: 10.1891/JCP-2022-0014 |
0.481 |
|
2023 |
Thompson KA, Miller AJ, Walsh EC, Bardone-Cone AM. Social media and disordered eating among middle-aged women: Not just an adolescent concern. Eating Behaviors. 50: 101748. PMID 37253297 DOI: 10.1016/j.eatbeh.2023.101748 |
0.534 |
|
2020 |
Bardone-Cone AM, Miller AJ, Thompson KA, Walsh EC. Predicting a comprehensive operationalization of eating disorder recovery: Examining self-concept, personality, and negative affect. The International Journal of Eating Disorders. PMID 32343432 DOI: 10.1002/Eat.23281 |
0.588 |
|
2020 |
Koller KA, Thompson KA, Miller AJ, Walsh EC, Bardone-Cone AM. Body appreciation and intuitive eating in eating disorder recovery. The International Journal of Eating Disorders. PMID 32020677 DOI: 10.1002/Eat.23238 |
0.594 |
|
2018 |
Rosenstein LK, Ellison WD, Walsh E, Chelminski I, Dalrymple K, Zimmerman M. The role of emotion regulation difficulties in the connection between childhood emotional abuse and borderline personality features. Personality Disorders. PMID 30091618 DOI: 10.1037/Per0000294 |
0.431 |
|
2018 |
Steinglass JE, Glasofer DR, Walsh E, Guzman G, Peterson CB, Walsh BT, Attia E, Wonderlich SA. Targeting habits in anorexia nervosa: a proof-of-concept randomized trial. Psychological Medicine. 1-8. PMID 29455696 DOI: 10.1017/S003329171800020X |
0.57 |
|
2017 |
Walsh E, Rosenstein L, Dalrymple K, Chelminski I, Zimmerman M. The Importance of Assessing for Childhood Abuse and Lifetime PTSD in Bariatric Surgery Candidates. Journal of Clinical Psychology in Medical Settings. PMID 29159539 DOI: 10.1007/S10880-017-9518-7 |
0.488 |
|
2017 |
Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Are self-report scales as effective as clinician rating scales in measuring treatment response in routine clinical practice? Journal of Affective Disorders. 225: 449-452. PMID 28858659 DOI: 10.1016/J.Jad.2017.08.024 |
0.491 |
|
2017 |
Zimmerman M, Walsh E, Friedman M, Boerescu DA, Attiullah N. Identifying Remission From Depression on 3 Self-Report Scales. The Journal of Clinical Psychiatry. 78: 177-183. PMID 28234434 DOI: 10.4088/Jcp.16M10641 |
0.498 |
|
2017 |
Zimmerman M, Walsh E, Chelminski I, Dalrymple K. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials? Journal of Affective Disorders. 211: 60-64. PMID 28088058 DOI: 10.1016/J.Jad.2017.01.008 |
0.558 |
|
2017 |
Dalrymple KL, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Modification of the medical exclusion criterion in DSM-5 social anxiety disorder: Comorbid obesity as an example. Journal of Affective Disorders. 210: 230-236. PMID 28064111 DOI: 10.1016/J.Jad.2016.12.055 |
0.491 |
|
2016 |
Yusufov M, Dalrymple K, Bernstein MH, Walsh E, Rosenstein L, Chelminski I, Zimmerman M. Body mass index, depression, and suicidality: The role of self-esteem in bariatric surgery candidates. Journal of Affective Disorders. 208: 238-247. PMID 27792969 DOI: 10.1016/J.Jad.2016.10.005 |
0.481 |
|
2016 |
Zimmerman M, Multach MD, Clark HL, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in late life depression antidepressant efficacy trials. International Journal of Geriatric Psychiatry. PMID 27546477 DOI: 10.1002/Gps.4560 |
0.502 |
|
2016 |
Zimmerman M, Holst CG, Clark HL, Multach M, Walsh E, Rosenstein LK, Gazarian D. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years. Cns Drugs. PMID 27541608 DOI: 10.1007/S40263-016-0381-0 |
0.586 |
|
2016 |
Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Variability in the substance use disorder exclusion criterion in antidepressant efficacy trials. Journal of Affective Disorders. 198: 39-42. PMID 27002283 DOI: 10.1016/J.Jad.2016.03.024 |
0.56 |
|
2016 |
Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Symptom Severity and the Generalizability of Antidepressant Efficacy Trials: Changes During the Past 20 Years. Journal of Clinical Psychopharmacology. PMID 26848791 DOI: 10.1097/Jcp.0000000000000466 |
0.519 |
|
2016 |
Zimmerman M, Multach M, Walsh E, Rosenstein LK, Gazarian D, Clark HL. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. Cns Drugs. PMID 26818632 DOI: 10.1007/S40263-016-0314-Y |
0.473 |
|
2015 |
Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling. Journal of Affective Disorders. 190: 357-361. PMID 26546771 DOI: 10.1016/J.Jad.2015.10.041 |
0.566 |
|
2015 |
Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 Years. Mayo Clinic Proceedings. 90: 1180-6. PMID 26276679 DOI: 10.1016/j.mayocp.2015.06.016 |
0.456 |
|
2015 |
Hidalgo-Mazzei D, Walsh E, Rosenstein L, Zimmerman M. Comorbid bipolar disorder and borderline personality disorder and substance use disorder. The Journal of Nervous and Mental Disease. 203: 54-7. PMID 25494335 DOI: 10.1097/Nmd.0000000000000235 |
0.546 |
|
2014 |
Zimmerman M, Morgan TA, Young D, Chelminski I, Dalrymple K, Walsh E. Does Borderline Personality Disorder Manifest Itself Differently in Patients With Bipolar Disorder and Major Depressive Disorder? Journal of Personality Disorders. 1-7. PMID 25248008 DOI: 10.1521/Pedi_2014_28_169 |
0.587 |
|
2014 |
Zimmerman M, Chelminski I, Young D, Dalrymple K, Walsh E, Rosenstein L. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder. The Journal of Clinical Psychiatry. 75: 601-7. PMID 24813209 DOI: 10.4088/Jcp.13M08961 |
0.59 |
|
Show low-probability matches. |